Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Daschle, Lambrew lead health reform office: President-elect Barack Obama formally announces his nomination Dec. 11 of former Senator Tom Daschle to head both the Department of Health and Human Services and the White House Office of Health Reform. Obama also nominates as deputy director of the White House office Jeanne Lambrew, the Office of Management and Budget's former health program associate director and co-author of Daschle's book on health care reform, "Critical." (1"The Tan Sheet" Nov. 24, 2008, p. 7). In his dual role, Daschle, who represented South Dakota in the Senate between 1987 and 2005, is expected to "be responsible, not just for implementing our health care plan, he will also be the lead architect of that plan," Obama says at a press conference. "Whether it's administering Medicare and Medicaid, keeping our food and pharmaceuticals safe, researching the cures of tomorrow, or investing in prevention and wellness, a well-functioning [HHS] can play a strong role in tackling the many health care challenges our country faces," Daschle says in accepting the nomination. Obama also praises Lambrew's health care policy and budget expertise, calling her "a leading thinker" on the issue of health reform. Lambew is currently a professor at the University of Texas' LBJ School of Public Affairs and a senior fellow at the Center for American Progress

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel